Liquid biopsies represent a groundbreaking advancement in the early detection and ongoing monitoring of breast cancer. By detecting cancer DNA in a blood sample, this non-invasive technique allows for the early identification of breast cancer, even before symptoms appear. Furthermore, liquid biopsies can monitor the genetic evolution of tumors in real-time, guiding adjustments in treatment strategies to counteract resistance and improve efficacy.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.